Table of Content

1 Venous Thromboembolism (VTE) Devices Market Overview
1.1 Product Overview and Scope of Venous Thromboembolism (VTE) Devices
1.2 Venous Thromboembolism (VTE) Devices Segment by Type
1.2.1 Global Venous Thromboembolism (VTE) Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Deep Vein Thrombosis(DVT)
1.2.3 Pulmonary Embolism(PE)
1.2.4 Others
1.3 Venous Thromboembolism (VTE) Devices Segment by Application
1.3.1 Venous Thromboembolism (VTE) Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Other
1.4 Global Venous Thromboembolism (VTE) Devices Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism (VTE) Devices Revenue 2016-2027
1.4.2 Global Venous Thromboembolism (VTE) Devices Sales 2016-2027
1.4.3 Venous Thromboembolism (VTE) Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Venous Thromboembolism (VTE) Devices Market Competition by Manufacturers
2.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Venous Thromboembolism (VTE) Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Venous Thromboembolism (VTE) Devices Manufacturing Sites, Area Served, Product Type
2.5 Venous Thromboembolism (VTE) Devices Market Competitive Situation and Trends
2.5.1 Venous Thromboembolism (VTE) Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism (VTE) Devices Players Market Share by Revenue
2.5.3 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Venous Thromboembolism (VTE) Devices Retrospective Market Scenario by Region
3.1 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
3.3.1 North America Venous Thromboembolism (VTE) Devices Sales by Country
3.3.2 North America Venous Thromboembolism (VTE) Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
3.4.1 Europe Venous Thromboembolism (VTE) Devices Sales by Country
3.4.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Venous Thromboembolism (VTE) Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region
3.5.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
3.6.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Country
3.6.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country
3.7.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Type
4.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2016-2021)
4.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2016-2021)
4.3 Global Venous Thromboembolism (VTE) Devices Price by Type (2016-2021)

5 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Application
5.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2016-2021)
5.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2016-2021)
5.3 Global Venous Thromboembolism (VTE) Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 ArjoHuntleigh
6.1.1 ArjoHuntleigh Corporation Information
6.1.2 ArjoHuntleigh Description and Business Overview
6.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ArjoHuntleigh Product Portfolio
6.1.5 ArjoHuntleigh Recent Developments/Updates
6.2 Armetheon
6.2.1 Armetheon Corporation Information
6.2.2 Armetheon Description and Business Overview
6.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Armetheon Product Portfolio
6.2.5 Armetheon Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Bio Compression Systems
6.4.1 Bio Compression Systems Corporation Information
6.4.2 Bio Compression Systems Description and Business Overview
6.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bio Compression Systems Product Portfolio
6.4.5 Bio Compression Systems Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Breg
6.6.1 Breg Corporation Information
6.6.2 Breg Description and Business Overview
6.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Breg Product Portfolio
6.6.5 Breg Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bristol-Myers Squibb Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cardinal Health Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 Currie Medical Specialties
6.9.1 Currie Medical Specialties Corporation Information
6.9.2 Currie Medical Specialties Description and Business Overview
6.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Currie Medical Specialties Product Portfolio
6.9.5 Currie Medical Specialties Recent Developments/Updates
6.10 Daiichi-Sankyo
6.10.1 Daiichi-Sankyo Corporation Information
6.10.2 Daiichi-Sankyo Description and Business Overview
6.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Daiichi-Sankyo Product Portfolio
6.10.5 Daiichi-Sankyo Recent Developments/Updates
6.11 Devon Medical Products
6.11.1 Devon Medical Products Corporation Information
6.11.2 Devon Medical Products Venous Thromboembolism (VTE) Devices Description and Business Overview
6.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Devon Medical Products Product Portfolio
6.11.5 Devon Medical Products Recent Developments/Updates
6.12 DJO
6.12.1 DJO Corporation Information
6.12.2 DJO Venous Thromboembolism (VTE) Devices Description and Business Overview
6.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 DJO Product Portfolio
6.12.5 DJO Recent Developments/Updates
6.13 Janssen
6.13.1 Janssen Corporation Information
6.13.2 Janssen Venous Thromboembolism (VTE) Devices Description and Business Overview
6.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Janssen Product Portfolio
6.13.5 Janssen Recent Developments/Updates
6.14 Mego Afek AC LTD
6.14.1 Mego Afek AC LTD Corporation Information
6.14.2 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Description and Business Overview
6.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Mego Afek AC LTD Product Portfolio
6.14.5 Mego Afek AC LTD Recent Developments/Updates
6.15 Normatec
6.15.1 Normatec Corporation Information
6.15.2 Normatec Venous Thromboembolism (VTE) Devices Description and Business Overview
6.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Normatec Product Portfolio
6.15.5 Normatec Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Venous Thromboembolism (VTE) Devices Description and Business Overview
6.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Pfizer Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Portola Pharmaceuticals
6.17.1 Portola Pharmaceuticals Corporation Information
6.17.2 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Description and Business Overview
6.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Portola Pharmaceuticals Product Portfolio
6.17.5 Portola Pharmaceuticals Recent Developments/Updates
6.18 ThermoTek USA
6.18.1 ThermoTek USA Corporation Information
6.18.2 ThermoTek USA Venous Thromboembolism (VTE) Devices Description and Business Overview
6.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.18.4 ThermoTek USA Product Portfolio
6.18.5 ThermoTek USA Recent Developments/Updates
6.19 Zimmer Biomet
6.19.1 Zimmer Biomet Corporation Information
6.19.2 Zimmer Biomet Venous Thromboembolism (VTE) Devices Description and Business Overview
6.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Zimmer Biomet Product Portfolio
6.19.5 Zimmer Biomet Recent Developments/Updates

7 Venous Thromboembolism (VTE) Devices Manufacturing Cost Analysis
7.1 Venous Thromboembolism (VTE) Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
7.4 Venous Thromboembolism (VTE) Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Venous Thromboembolism (VTE) Devices Distributors List
8.3 Venous Thromboembolism (VTE) Devices Customers

9 Venous Thromboembolism (VTE) Devices Market Dynamics
9.1 Venous Thromboembolism (VTE) Devices Industry Trends
9.2 Venous Thromboembolism (VTE) Devices Growth Drivers
9.3 Venous Thromboembolism (VTE) Devices Market Challenges
9.4 Venous Thromboembolism (VTE) Devices Market Restraints

10 Global Market Forecast
10.1 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
10.2 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
10.3 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Venous Thromboembolism (VTE) Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Venous Thromboembolism (VTE) Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Venous Thromboembolism (VTE) Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Venous Thromboembolism (VTE) Devices Covered in This Study
Table 5. Global Venous Thromboembolism (VTE) Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Venous Thromboembolism (VTE) Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Venous Thromboembolism (VTE) Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Venous Thromboembolism (VTE) Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Venous Thromboembolism (VTE) Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Venous Thromboembolism (VTE) Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Venous Thromboembolism (VTE) Devices Product Type
Table 12. Global Venous Thromboembolism (VTE) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Venous Thromboembolism (VTE) Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Thromboembolism (VTE) Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Venous Thromboembolism (VTE) Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2016-2021)
Table 17. Global Venous Thromboembolism (VTE) Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Venous Thromboembolism (VTE) Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2016-2021)
Table 20. North America Venous Thromboembolism (VTE) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Venous Thromboembolism (VTE) Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Venous Thromboembolism (VTE) Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Venous Thromboembolism (VTE) Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Venous Thromboembolism (VTE) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Venous Thromboembolism (VTE) Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2016-2021)
Table 40. Global Venous Thromboembolism (VTE) Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Venous Thromboembolism (VTE) Devices Revenue Share by Type (2016-2021)
Table 42. Global Venous Thromboembolism (VTE) Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Venous Thromboembolism (VTE) Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2016-2021)
Table 45. Global Venous Thromboembolism (VTE) Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Venous Thromboembolism (VTE) Devices Revenue Share by Application (2016-2021)
Table 47. Global Venous Thromboembolism (VTE) Devices Price (US$/Unit) by Application (2016-2021)
Table 48. ArjoHuntleigh Corporation Information
Table 49. ArjoHuntleigh Description and Business Overview
Table 50. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product
Table 52. ArjoHuntleigh Recent Developments/Updates
Table 53. Armetheon Corporation Information
Table 54. Armetheon Description and Business Overview
Table 55. Armetheon Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Armetheon Venous Thromboembolism (VTE) Devices Product
Table 57. Armetheon Recent Developments/Updates
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Business Overview
Table 60. Bayer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Bayer Venous Thromboembolism (VTE) Devices Product
Table 62. Bayer Recent Developments/Updates
Table 63. Bio Compression Systems Corporation Information
Table 64. Bio Compression Systems Description and Business Overview
Table 65. Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Bio Compression Systems Venous Thromboembolism (VTE) Devices Product
Table 67. Bio Compression Systems Recent Developments/Updates
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Product
Table 72. Boehringer Ingelheim Recent Developments/Updates
Table 73. Breg Corporation Information
Table 74. Breg Description and Business Overview
Table 75. Breg Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Breg Venous Thromboembolism (VTE) Devices Product
Table 77. Breg Recent Developments/Updates
Table 78. Bristol-Myers Squibb Corporation Information
Table 79. Bristol-Myers Squibb Description and Business Overview
Table 80. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Product
Table 82. Bristol-Myers Squibb Recent Developments/Updates
Table 83. Cardinal Health Corporation Information
Table 84. Cardinal Health Description and Business Overview
Table 85. Cardinal Health Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Cardinal Health Venous Thromboembolism (VTE) Devices Product
Table 87. Cardinal Health Recent Developments/Updates
Table 88. Currie Medical Specialties Corporation Information
Table 89. Currie Medical Specialties Description and Business Overview
Table 90. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Product
Table 92. Currie Medical Specialties Recent Developments/Updates
Table 93. Daiichi-Sankyo Corporation Information
Table 94. Daiichi-Sankyo Description and Business Overview
Table 95. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Product
Table 97. Daiichi-Sankyo Recent Developments/Updates
Table 98. Devon Medical Products Corporation Information
Table 99. Devon Medical Products Description and Business Overview
Table 100. Devon Medical Products Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Devon Medical Products Venous Thromboembolism (VTE) Devices Product
Table 102. Devon Medical Products Recent Developments/Updates
Table 103. DJO Corporation Information
Table 104. DJO Description and Business Overview
Table 105. DJO Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. DJO Venous Thromboembolism (VTE) Devices Product
Table 107. DJO Recent Developments/Updates
Table 108. Janssen Corporation Information
Table 109. Janssen Description and Business Overview
Table 110. Janssen Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Janssen Venous Thromboembolism (VTE) Devices Product
Table 112. Janssen Recent Developments/Updates
Table 113. Mego Afek AC LTD Corporation Information
Table 114. Mego Afek AC LTD Description and Business Overview
Table 115. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Product
Table 117. Mego Afek AC LTD Recent Developments/Updates
Table 118. Normatec Corporation Information
Table 119. Normatec Description and Business Overview
Table 120. Normatec Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Normatec Venous Thromboembolism (VTE) Devices Product
Table 122. Normatec Recent Developments/Updates
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Business Overview
Table 125. Pfizer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Pfizer Venous Thromboembolism (VTE) Devices Product
Table 127. Pfizer Recent Developments/Updates
Table 128. Portola Pharmaceuticals Corporation Information
Table 129. Portola Pharmaceuticals Description and Business Overview
Table 130. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Product
Table 132. Portola Pharmaceuticals Recent Developments/Updates
Table 133. ThermoTek USA Corporation Information
Table 134. ThermoTek USA Description and Business Overview
Table 135. ThermoTek USA Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. ThermoTek USA Venous Thromboembolism (VTE) Devices Product
Table 137. ThermoTek USA Recent Developments/Updates
Table 138. Zimmer Biomet Corporation Information
Table 139. Zimmer Biomet Description and Business Overview
Table 140. Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Zimmer Biomet Venous Thromboembolism (VTE) Devices Product
Table 142. Zimmer Biomet Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Venous Thromboembolism (VTE) Devices Distributors List
Table 146. Venous Thromboembolism (VTE) Devices Customers List
Table 147. Venous Thromboembolism (VTE) Devices Market Trends
Table 148. Venous Thromboembolism (VTE) Devices Growth Drivers
Table 149. Venous Thromboembolism (VTE) Devices Market Restraints
Table 150. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 151. Global Venous Thromboembolism (VTE) Devices Sales Market Share Forecast by Type (2022-2027)
Table 152. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 155. Global Venous Thromboembolism (VTE) Devices Sales Market Share Forecast by Application (2022-2027)
Table 156. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 159. Global Venous Thromboembolism (VTE) Devices Sales Market Share Forecast by Region (2022-2027)
Table 160. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Venous Thromboembolism (VTE) Devices
Figure 2. Global Venous Thromboembolism (VTE) Devices Market Share by Type in 2020 & 2027
Figure 3. Deep Vein Thrombosis(DVT) Product Picture
Figure 4. Pulmonary Embolism(PE) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Venous Thromboembolism (VTE) Devices Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Surgical Centers
Figure 9. Other
Figure 10. Global Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Venous Thromboembolism (VTE) Devices Market Size 2016-2027 (US$ Million)
Figure 12. Global Venous Thromboembolism (VTE) Devices Sales 2016-2027 (K Units)
Figure 13. Global Venous Thromboembolism (VTE) Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Venous Thromboembolism (VTE) Devices Sales Share by Manufacturers in 2020
Figure 15. Global Venous Thromboembolism (VTE) Devices Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Venous Thromboembolism (VTE) Devices Players: Market Share by Revenue in 2020
Figure 17. Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2016-2021)
Figure 19. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Region in 2020
Figure 20. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Region (2016-2021)
Figure 21. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Region in 2020
Figure 22. U.S. Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Venous Thromboembolism (VTE) Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Venous Thromboembolism (VTE) Devices by Type (2016-2021)
Figure 47. Sales Market Share of Venous Thromboembolism (VTE) Devices by Application (2016-2021)
Figure 48. Sales Market Share of Venous Thromboembolism (VTE) Devices by Application in 2020
Figure 49. Revenue Share of Venous Thromboembolism (VTE) Devices by Application (2016-2021)
Figure 50. Revenue Share of Venous Thromboembolism (VTE) Devices by Application in 2020
Figure 51. Manufacturing Cost Structure of Venous Thromboembolism (VTE) Devices
Figure 52. Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
Figure 53. Venous Thromboembolism (VTE) Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed